Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.
Das S, Chauhan A, Du L, Thomas KE, Jacob A, Schad A, Jain S, Jessop A, Shah C, Eisner D, Cardin DB, Ciombor KK, Goff LW, Bradshaw M, Delbeke D, Sandler M, Ramirez RA, Berlin J. Das S, et al. Among authors: goff lw. JAMA Netw Open. 2022 Jan 4;5(1):e2144170. doi: 10.1001/jamanetworkopen.2021.44170. JAMA Netw Open. 2022. PMID: 35044469 Free PMC article.
Aurora kinase inhibitors--rising stars in cancer therapeutics?
Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W. Dar AA, et al. Among authors: goff lw. Mol Cancer Ther. 2010 Feb;9(2):268-78. doi: 10.1158/1535-7163.MCT-09-0765. Epub 2010 Feb 2. Mol Cancer Ther. 2010. PMID: 20124450 Free PMC article. Review.
Advances in the management of biliary tract cancers.
Ciombor KK, Goff LW. Ciombor KK, et al. Among authors: goff lw. Clin Adv Hematol Oncol. 2013 Jan;11(1):28-34. Clin Adv Hematol Oncol. 2013. PMID: 23416860 Free PMC article. Review.
Advanced biliary tract cancers.
Goff LW, Berlin JD. Goff LW, et al. Am Soc Clin Oncol Educ Book. 2012:281-2. doi: 10.14694/EdBook_AM.2012.32.203. Am Soc Clin Oncol Educ Book. 2012. PMID: 24451749 Free article.
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.
Cardin DB, Goff L, Li CI, Shyr Y, Winkler C, DeVore R, Schlabach L, Holloway M, McClanahan P, Meyer K, Grigorieva J, Berlin J, Chan E. Cardin DB, et al. Cancer Med. 2014 Jun;3(3):572-9. doi: 10.1002/cam4.208. Epub 2014 Feb 12. Cancer Med. 2014. PMID: 24574334 Free PMC article. Clinical Trial.
A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors.
Puzanov I, Lindsay CR, Goff L, Sosman J, Gilbert J, Berlin J, Poondru S, Simantov R, Gedrich R, Stephens A, Chan E, Evans TR. Puzanov I, et al. Clin Cancer Res. 2015 Feb 15;21(4):701-11. doi: 10.1158/1078-0432.CCR-14-0303. Epub 2014 Sep 11. Clin Cancer Res. 2015. PMID: 25212606 Clinical Trial.
56 results